BioPerfectus
Biotechnology Empowers the Perfection of Human Life

Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

800+

Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

90 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

10000 Machinery spots

Bioperfectus Nucleic Acid Extraction Solutions 
were launched in over 10,000 laboratories 
globally with a well-trained and quick-response 
customer service team.

News Center
04-082022
Four Different Dengue Serotypes that Worth Your Attention
Four Different Dengue Serotypes that Worth Your Attention
04-082022
Dengue is caused by infection with dengue virus (DENV), a member of the genus Flavivirus, family Flaviviridae. In 128 countries, 400 million people are infected each year, and 3.9 billion people are at risk of infection with dengue viruses. Yet the number of infectious countries and cases is still increasing, mainly in Africa, the Americas, Asia, the Caribbean, and the Pacific(Fig 1). In 2021, the five countries reporting the most cases were Brazil, India, Vietnam, the Philippines, and Colomb...
05-072022
Bioperfectus Emergency Response to the Unknown Hepatitis in Children
Bioperfectus Emergency Response to the Unknown Hepatitis in Children
05-072022
On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases. How many countries have reported confirmed or suspected cases of unknown hepatitis in children? According to WHO, as of 21 April 2022, at least 169 cases of acute hepatitis of unknown origin have been reported from 11 countries in the WHO European Region and one country...
05-122022
Compact and Powerful, SSNP-2000B Promotes Molecular Detection Ability
Compact and Powerful, SSNP-2000B Promotes Molecular Detection Ability
05-122022
After SSNP-2000B got the IF award, its application in nucleic acid detection grew with stronger momentum. Conquering the judges with exclusive features, SSNP-2000B also obtained more and more recognition from clinical operators. SSNP-2000B got approval from technicians in Portugal For now, SSNP-2000B has won hearts from more than 80 laboratories, which cover more than 25 countries. BioPerfectus SSNP-2000B is a small but fully functional extractor. 1-32 samples can be extracted wit...
Service Network
Support is only one step away
A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.
CONTACT US NOW